Cardio-Oncology is affiliated with the International Cardio-Oncology Society (ICOS).
Healthcare disparities in cardio oncology: patients receive same level of surveillance regardless of race at a safety net hospital
Cardiotoxicity remains a dreaded complication for patients undergoing chemotherapy with human epidermal growth factor (HER)-2 receptor antagonists and anthracyclines. Though many studies have looked at racial ...
Citation: Cardio-Oncology 2021 7:3